- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Hologic revenues trend downward
Other headlinesCardinal Health to add radiopharmacies
Hologic revenues trend downward
Third quarter revenues dipped 6.1% at Hologic to $403.1 million from the year earlier, due primarily to falling demand for the company’s digital mammography systems. Company execs blamed the dismal economic conditions for delays and cuts in hospital capital spending. The company still generated net income of $41.0 million, albeit down from the previous year’s 3Q net income of $61.4 million. Previous success selling digital mammography units bolstered the bottom line, as the company generated a 23.8% increase in service and other revenues related primarily to its installed base of the Selenia systems. Company execs reaffirmed the low-end and tightened the top-end of its fiscal 2009 revenue guidance, predicting fourth quarter revenues between $390 million and $400 million, which would be slightly lower than those in 3Q.
Cardinal Health to add radiopharmacies
Cardinal Health has agreed to acquire the assets of privately held Biotech, an operator of PET cyclotrons and nuclear pharmacies in the U.S. Southwest. Biotech's four nuclear pharmacies, which will be acquired for an undisclosed amount, will expand Cardinal Health’s PET business in Arizona, Nevada, New Mexico and Texas. The company operates about 160 nuclear pharmacies and 26 cyclotron-based PET radiopharmaceutical manufacturing facilities.
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
